Data that can stand behind the story
Fit-for-purpose assays with attention to sensitivity, specificity, matrix effects, reproducibility, and lot consistency.
Translational assay infrastructure for U.S.-ready biotech programs
VexisBio helps biotech and diagnostic teams turn complex biomarker and biologic ideas into credible assays, validation plans, and U.S.-facing scientific packages.
San Diego, CAU.S.-based partner
High-sensitivityassay expertise
To-USAscientific translation
From global innovation to U.S.-ready translational value.
We combine assay science, cross-border execution, and U.S.-facing technical communication to help promising programs become easier to evaluate, partner, and advance.
Clear U.S.-facing narratives
Validation plans, performance summaries, and technical materials for partners, investors, and regulatory-facing teams.
Translation beyond language
Bilingual scientific communication and practical U.S. operations for international biotech and diagnostic programs.
Core capabilities
Products support the work, but the main value is turning complex science into credible, useful evidence.
Biomarker assays
- Custom ELISA and immunoassays
- Serum, plasma, CSF, and tissue matrices
- High-sensitivity platform planning
Antibody and ELISA development
- Antibody pairing and qualification
- Capture/detection optimization
- Reagent QC and lot consistency
ELISA-qPCR workflows
- Antibody-oligo concepts
- qPCR-readable protein readouts
- Conjugation workflow support
Translational readiness
- Validation planning
- Technical summaries
- Partner and investor packages
Focused programs
We concentrate where assay science, translational judgment, and cross-border execution create the most leverage.
Alzheimer's and aging biomarkers
Plasma/CSF protein and RNA biomarkers with high-sensitivity assay development and validation planning.
ELISA-qPCR and conjugation
Antibody-oligo conjugation, qPCR-readable immunoassay concepts, and sensitive protein readouts.
Reagents and raw materials
Recombinant proteins, antibodies, standards, and controls as supporting assets for assay development.
Let's build your U.S.-ready program.
Whether you are a biotech founder, diagnostics team, investor, or partner evaluating a international program, VexisBio can help shape the next experimental and translational step.
Discuss a Program